Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Blocking certain receptors in the lungs might help treat a specific type of asthma.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Compound glycyrrhizin combined with conventional treatments effectively and safely promotes hair regrowth in alopecia areata patients.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Three genes in Arabidopsis are important for plant growth and development by affecting sugar attachment to proteins.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Bhangra may help treat premature greying of hair by boosting melanin and improving scalp health.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Baricitinib helps treat severe hair loss in people over 65.

Liquorice and Indian jujube root extracts don't help in fighting male pattern baldness.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

GLP-1 agonists may increase the risk of hair loss.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.

IVIg treatment improved symptoms but caused permanent dark hair loss.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Baricitinib was effective in treating alopecia areata in two major trials.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Valproate can cause hair problems, but there are ways to manage them.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

Baricitinib helps with early hair regrowth in people with alopecia areata.